New hope for lymphoma patients after chemo fails
Disease control
Completed
This study tested whether the drug brentuximab vedotin could help control T-cell lymphoma that had returned or stopped responding to previous chemotherapy. The trial enrolled 23 patients whose cancer cells had low levels of a specific target called CD30. Researchers wanted to see…
Phase: PHASE2 • Sponsor: Deepa Jagadeesh • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC